Immunotherapy Foundation (IF) is a non-profit organization that strategically funds the most promising cancer immunotherapy research, focused on HPV-driven cancers. IF works directly with world-class researchers to accelerate the discovery and development of new and improved immunotherapies for patients, by translating multiple research projects into the clinical setting and creating a robust portfolio of preclinical immunotherapies and award-winning research at the University of California – San Diego (UCSD) and the La Jolla Institute for Allergy and Immunology (LIAI), as recognized by the Cancer Research Institute.

IF is building educational programming around HPV vaccination and screening, with a focus on the link to cancer. IF is also creating a digital portal of the latest news and resources regarding HPV, HPV-related cancers, and immunotherapy treatments. The organization is investigating partnerships and alliances to help amplify existing education and advocacy initiatives, and build out regional, national and international efforts to reduce incidence of HPV and thus HPV-related cancers.